We attended this year’s AACR meeting and wanted to thank everyone for such an incredible turnout and experience as we introduced Bruker Cellular Analysis to many of you for the first time. We had a great time speaking with so many amazing researchers that are enthusiastic about our technology, and loved to see all of […]
While CAR-T therapies have been revolutionary in the fight against cancer, current FDA approvals for these therapies focus on targeting CD19 or BCMA in B-cell malignancies. Unfortunately, of the patients treated, only up to 50% maintain a sustained response in the long-term. Relapse can occur when cancer adaptively limits CD19 or BCMA expression to render
With the coming together of Berkeley Lights and IsoPlexis, Bruker Cellular Analysis is positioned to power labs across the new frontier of biological and medicinal research. We are uniquely enabling the exploration of the phenome and mastery of single cells for all labs and scientists. Our platform now powers all stages across the discovery and
Bruker Cellular Analysis: Driving the Next Wave of Biological Breakthroughs Read More »
Explore the Bruker Cellular Analysis Blog and learn more about Bruker Cellular Analysis and how we are uniquely enabling the exploration of the phenome and mastery of single cells for all labs & scientists.
Cellular Analysis Blog Read More »
